We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPAI
2976
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$194K ﹤0.01%
15,915
-3,114
-16% -$40.8K
KED
2977
DELISTED
Kayne Anderson Energy
KED
$194K ﹤0.01%
+10,691
New +$197K
EHI
2978
Western Asset Global High Income Fund
EHI
$177M
$190K ﹤0.01%
18,862
+1,697
+10% +$17.3K
HON icon
2979
CALL
Honeywell
HON
$78.6B
$190K ﹤0.01%
36,309
+10,295
+40% +$1.21M
PHD
2980
DELISTED
Pioneer Floating Rate Fund
PHD
$188K ﹤0.01%
15,816
+2,554
+19% +$30.9K
CDTX
2981
DELISTED
Cidara Therapeutics
CDTX
$187K ﹤0.01%
+1,246
New +$172K
DXD icon
2982
ProShares UltraShort Dow 30
DXD
$37.7M
$187K ﹤0.01%
785
NCV
2983
Virtus Convertible & Income Fund
NCV
$388M
$187K ﹤0.01%
6,699
+881
+15% +$24.4K
SFM icon
2984
CALL
Sprouts Farmers Market
SFM
$7.94B
$187K ﹤0.01%
101,100
+37,600
+59% +$871K
BOJA
2985
DELISTED
Bojangles', Inc. Common Stock
BOJA
$187K ﹤0.01%
11,525
+900
+8% +$16.6K
IMUX icon
2986
Immunic
IMUX
$191M
$186K ﹤0.01%
161
+60
+59% +$80.1K
MUC icon
2987
BlackRock MuniHoldings California Quality Fund
MUC
$1B
$185K ﹤0.01%
12,791
+1,396
+12% +$20K
CAE icon
2988
CAE Inc. Common Shares
CAE
$8.62B
$184K ﹤0.01%
10,678
-2,249
-17% -$35.8K
ASG
2989
Liberty All-Star Growth Fund
ASG
$340M
$183K ﹤0.01%
37,106
+4,379
+13% +$20.7K
ACNT icon
2990
Ascent Industries
ACNT
$141M
$181K ﹤0.01%
16,000
EMF
2991
Templeton Emerging Markets Fund
EMF
$328M
$180K ﹤0.01%
12,045
+791
+7% +$11.6K
VGI
2992
Virtus Global Multi-Sector Income Fund
VGI
$82.7M
$180K ﹤0.01%
10,502
-25,314
-71% -$424K
NTBL
2993
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$180K ﹤0.01%
1,153
+729
+172% +$138K
ASA
2994
ASA Gold and Precious Metals
ASA
$1.03B
$179K ﹤0.01%
15,272
+1,200
+9% +$14.4K
MUH
2995
DELISTED
Blackrock Muniholdings Fund II, Inc.
MUH
$179K ﹤0.01%
11,322
-19,795
-64% -$311K
DNR
2996
DELISTED
Denbury Resources, Inc.
DNR
$179K ﹤0.01%
116,961
-4,200
-3% -$7.85K
AUPH icon
2997
Aurinia Pharmaceuticals
AUPH
$1.95B
$178K ﹤0.01%
+29,000
New +$195K
MCBC
2998
DELISTED
Macatawa Bank Corp
MCBC
$178K ﹤0.01%
18,610
+7,000
+60% +$67.1K
PCM
2999
PCM Fund
PCM
$70.8M
$177K ﹤0.01%
15,774
WEA
3000
Western Asset Premier Bond Fund
WEA
$124M
$177K ﹤0.01%
12,650
-2,161
-15% -$29.5K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.